Annabel can take her meds and enjoy her life 

Annabel can take her meds and enjoy her life 
Annabel Murphy (aged 8) who has cystic fibrosis with Prof. Paul McNally, RCSI Associate Professor of Paediatrics at the launch of a new €3m study, led by RCSI, to investigate the real-world effects of a new cystic fibrosis medication.

New cystic fibrosis medication means the future is much brighter for children such as Annabel Murphy.

Annabel was tested for CF as part of the newborn bloodspot programme that was introduced here in 2011.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited